ALB and cancer: Based on the exclusion criteria, 40 patients were excluded (5 with secondary IgAN, 6 with ESRD at admission, 13 with conditions affecting albumin and fibrinogen levels, 7 with malignancies, and 9 without complete data), and 245 patients were ultimately enrolled in the analysis.